Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinoma

16 Apr 2018

Abstract excerpt

// Yoshiyuki Yamamoto 1 , Motohide Uemura 1, 2 , Kosuke Nakano 1 , Yujiro Hayashi 1 , Cong Wang 1 , Yu Ishizuya 1 , Toshiro Kinouchi 1 , Takuji Hayashi 1 , Kyosuke Matsuzaki 1 , Kentaro Jingushi 2 , Taigo Kato 1 , Atsunari Kawashima 1 , Takeshi Ujike 1 , Akira Nagahara 1 , Kazutoshi Fujita 1 , Ryoichi Imamura 1 and Norio Nonomura 1 1 Department of Urology, Osaka University Graduate School of Medicine, Suita...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29755665
DOI: 10.18632/oncotarget.24943

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinomaPMID 29755665Read ↗

Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinomaSemantic proximity Read ↗

Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseasesSemantic proximity Read ↗

The amount of circulating DNA and the presence of TP53 mutations in plasma predict clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIsSemantic proximity Read ↗

Circulating Non-coding RNAs in Renal Cell Carcinoma—Pathogenesis and Potential Implications as Clinical BiomarkersSemantic proximity Read ↗

Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer ManagementSemantic proximity Read ↗

Technical Advances in Circulating Cell-Free DNA Detection and Analysis for Personalized Medicine in Patients’ CareSemantic proximity Read ↗

Concentration of cell-free DNA in different tumor typesSemantic proximity Read ↗

Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and OutlookSemantic proximity Read ↗

Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoringSemantic proximity Read ↗

Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.Semantic proximity Read ↗

The emerging role of cell-free DNA as a molecular marker for cancer managementSemantic proximity Read ↗

Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients’ Management and Therapy OutcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.